These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24165277)

  • 21. Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.
    Santos EA; Sucupira MV; Arabe J; Gomes SA
    BMC Infect Dis; 2004 Aug; 4():29. PubMed ID: 15339340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
    Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains.
    Amini-Bavil-Olyaee S; Vucur M; Luedde T; Trautwein C; Tacke F
    J Virol; 2010 Jan; 84(2):1026-33. PubMed ID: 19889778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.
    Torresi J
    J Clin Virol; 2002 Aug; 25(2):97-106. PubMed ID: 12367644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.
    Bottecchia M; Souto FJ; O KM; Amendola M; Brandão CE; Niel C; Gomes SA
    BMC Microbiol; 2008 Jan; 8():11. PubMed ID: 18211717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
    Feng B; Wei L; Chen M; Wang L
    Microbiol Res; 2008; 163(4):487-92. PubMed ID: 17317127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
    Ohishi W; Shirakawa H; Kawakami Y; Kimura S; Kamiyasu M; Tazuma S; Nakanishi T; Chayama K
    J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
    Zhu Y; Curtis M; Borroto-Esoda K
    Antivir Chem Chemother; 2011 Aug; 22(1):13-22. PubMed ID: 21860069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
    Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
    J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of hepatitis virus B isolated from a multi-drug refractory patient.
    Wei C; Chong YT; Wen JZ; Li YW; Li G
    Virus Res; 2011 Jan; 155(1):254-8. PubMed ID: 20970466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.
    Silva AC; Spina AM; Lemos MF; Oba IT; Guastini Cde F; Gomes-Gouvêa MS; Pinho JR; Mendes-Correa MC
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):770-8. PubMed ID: 20944991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
    Xu Z; Liu Y; Xu T; Chen L; Si L; Wang Y; Ren X; Zhong Y; Zhao J; Xu D
    J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
    Kazim SN; Sarin SK; Sharma BC; Khan LA; Hasnain SE
    Intervirology; 2006; 49(3):152-60. PubMed ID: 16428891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
    Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
    Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
    Lee SY; Choi MS; Lee D; Lee JH; Koh KC; Paik SW; Yoo BC
    J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
    Sayan M; Akhan SC
    Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
    Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G
    Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
    Ayres A; Bartholomeusz A; Lau G; Lam KC; Lee JY; Locarnini S
    J Clin Virol; 2003 May; 27(1):111-6. PubMed ID: 12727536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
    Lee YS; Chung YH; Kim JA; Kim SE; Shin JW; Kim KM; Lim YS; Park NH; Lee HC; Lee YS; Suh DJ
    Liver Int; 2009 Apr; 29(4):552-6. PubMed ID: 19323782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.